Physician profile
Sana Ali
NPI 1699268482
$1,512.85
in general payments reported to CMS, 2019-2025
18 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $391 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.48 |
| Education | $107.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $594.41 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $173.23 | 2025 | Fasenra, Breztri |
| Glaxosmithkline, LLC. | $142.98 | 2025 | Nucala, Trelegy Ellipta |
| Astellas Pharma US INC | $137.03 | 2024-2025 | Izervay |
| Mylan Specialty L.P. | $94.79 | 2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $62.78 | 2025 | Uptravi |
| Insmed, INC. | $55.33 | 2025 | Arikayce |
| Grifols USA, LLC | $40.20 | 2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.03 | 2025 | Jascayd |
| Apellis Pharmaceuticals, INC. | $33.56 | 2025 | Syfovre |
| La Jolla Pharmaceutical Company | $24.44 | 2024 | Giapreza |
| Tactile Systems Technology INC | $21.01 | 2024 | Flexitouch Plus, Entre Plus |
| Viatris Specialty LLC | $19.89 | 2025 | Yupelri |
| Verona Pharma, INC. | $17.21 | 2025 | Ohtuvayre |
| Amgen INC. | $16.95 | 2025 | Tezspire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.45 | 2024 | (Ak6) Vest Therapy |
| Baxter Healthcare | $13.89 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Medtronic, INC. | $13.67 | 2025 | Illumisite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.